From Mechanism to Manufacture: A Narrative Review of Insole Interventions Across Foot Deformity, Limb-Length Discrepancy, and Paediatric Orthopaedic Disease

Insoles are among the most widely prescribed devices in orthopaedic practice, spanning conditions as mechanically dissimilar as paediatric flexible flatfoot, painful pes cavus, diabetic neuropathy, inflammatory arthritis, medial knee osteoarthritis, limb-length discrepancy, and neuromuscular gait disorders. Despite this breadth, the field is characterised by a persistent and instructive paradox: the biomechanical effects of insoles are reproducible and quantifiable, whereas their symptomatic effects are inconsistent and frequently indistinguishable from sham. This narrative review, drawing on a bounded, non-systematic evidence base of 55 sources across ten conditions, argues that this paradox is at least partly an engineering and measurement problem rather than a purely clinical one. We develop a mechanistic taxonomy in which every insole acts through some combination of four pathways—plantar pressure redistribution, external joint moment modulation, soft-tissue strain reduction, and sensorimotor modulation—and map the controllable design parameters (arch support height, medial posting angle, heel cup depth, thickness, material stiffness, and lattice architecture) onto each pathway using sensitivity data from a small number of heterogeneous finite element and Taguchi-based optimisation studies, several of which are single-model or single-patient analyses with limited experimental validation. We then review the manufacturing pathway from morphological capture through computer-aided design, additive or subtractive fabrication, and in-shoe verification, and summarise the condition-specific clinical evidence across the ten indications. Three hypothesis-generating findings emerge, each requiring prospective confirmation before being treated as established. First, custom devices consistently modify mechanics more than prefabricated devices, yet consistently fail to outperform them on symptom endpoints, indicating that the mechanism–outcome link is mediated by unmeasured variables. Second, the biomechanical response is heterogeneous in several conditions—for example, roughly one-third of patients with medial knee osteoarthritis show an increase rather than a decrease in the knee adduction moment with a lateral wedge—raising the possibility that population-averaged trials may obscure responder-specific effects, although the one trial that acted on this logic by individually tailoring the wedge angle found no clinical benefit. Third, a secondary analysis of a single randomised trial in painful pes cavus found that the redistribution, rather than magnitude, of plantar pressure predicted pain relief; if replicated, this would suggest that peak plantar pressure is an incomplete outcome measure in that specific pain-related context, a claim we do not extend to conditions such as diabetic offloading, where peak local pressure remains a mechanistically appropriate proxy for a different, site-specific outcome. We propose a design-decision framework, presented explicitly as a falsifiable hypothesis rather than a validated protocol, that selects design parameters by target mechanism rather than by diagnostic label, and argue that closed-loop prescription—instrumented insoles providing the continuous verification of both mechanical target attainment and wear adherence—is a promising but as-yet-unproven direction for the field.